Wednesday, September 29, 2010

Daily Business Update from the Boston Globe

To ensure you receive your Boston.com e-mails, please add newsletters@boston.com to your address book.

If you have trouble reading this e-mail, go to http://www.boston.com/business/ticker_headlines


Get up-to-the-minute Globe Business Updates   |  More Business News
 
ADVERTISEMENT

Globe Today

Wednesday, September 29, 2010

Rosengren: Do more to lower unemployment
The Federal Reserve should do more to lower unemployment, and be willing to take unconventional steps, such as buying government securities, to generate faster economic growth, said Eric Rosengren, president of the Boston Fed.

More workers skip lunch, poll finds
Possibly because of hard times, the workplace lunch break may be going the way of the pay raise and the 37.5 hour work week as a new poll finds that fewer than half of employees can find time to take a lunch break.

Who, What, Where
A sample of personnel announcements from local firms.

Columbia Management signs lease at 225 Franklin
The financial services firm Columbia Management is moving to a Boston office tower at 225 Franklin St., taking 156,000 square feet in one of the largest leases this year.

Liberty Mutual postpones unit’s IPO
Liberty Mutual Group said today that it is postponing the initial public offering of stock in Liberty Mutual Agency Corp., citing a poor economic climate for an IPO.

Advisor targeted elderly investors, Galvin charges
The office of Massachusetts Secretary of State William F. Galvin said that it has charged a South Yarmouth financial advisor with diverting money from elderly investors to a company she controlled.

Gilbane to direct regional operations from Boston
Gilbane Building Co., a national construction company, said that it will now direct its growing business in New England from Boston.

Mersana Therapeutics has a new CEO
Mersana Therapeutics, a platform-based cancer therapeutics company, announced the appointment of Nicholas G. Bacopoulos as president and chief executive.

Ligon will collaborate with Bayer Schering Pharma
Ligon Discovery said it has partnered with Bayer Schering Pharma AG of Germany, which will apply Ligon Discovery's proprietary small molecule microarray screening platform to discover new drug candidates.

Today in Globe Business
A sample of Business stories from today's Globe.

No comments:

Post a Comment